Clinical Trial Update: Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update regarding ROBO1-specific BiCAR-NK cells for pancreatic cancer in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ROBO1-specific BiCAR-NK cells

Snippet

Sponsor: Asclepius Technology Company Group (Suzhou) Co., Ltd. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN